Ashwani Mittal
Papers
1
Total Citations
113
H-Index
1
About
Dr. Ashwani Mittal has made transformative contributions to our understanding of skeletal muscle pathophysiology, particularly in the context of muscle wasting diseases. His research focuses on the molecular mechanisms driving extracellular matrix degradation, a critical yet poorly understood process in conditions like cachexia and muscular dystrophies. In his landmark 2008 study, cited over 113 times, Dr. Mittal revealed how Tumor Necrosis Factor-related Weak Inducer of Apoptosis (TWEAK) amplifies matrix metalloproteinase-9 (MMP-9) production in skeletal muscle. He demonstrated that this occurs through the coordinated activation of nuclear factor-κB-inducing kinase and p38 mitogen-activated protein kinase pathways, providing the first mechanistic insight into how inflammatory signals trigger extracellular matrix breakdown. This work established a novel paradigm linking immune signaling to muscle tissue destruction, opening new therapeutic avenues for preventing muscle wasting. Dr. Mittal’s pioneering use of microarray approaches to identify these pathways exemplifies his innovative experimental design. His findings have profound implications for developing targeted interventions against the devastating muscle loss seen in cancer, sepsis, and chronic inflammatory diseases, cementing his reputation as a leading figure in muscle biology and inflammation research.
Research Focus
Key Achievements
Top Papers
- 1